Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Single-dose HPV vaccine recommendation is a “game changer” for cervical cancer elimination
Just one dose of the human papillomavirus (HPV) vaccine is enough to provide sufficient protection…
New platform optimizes selection of combination cancer therapies
Researchers at The University of Texas MD Anderson Cancer Center in the USA have developed…
Cannabis and Cancer: Oncology News Q&A with Dr James Stewart
Dr Stewart, who was recently awarded Australian Doctor of the Year and the People’s Choice…
Why we’re looking for cancer clues in urine
Barbara Guinn, University of Hull The human immune system is actually quite good at killing cancer cells. In fact, we…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.